Researchers are testing "NikVax," a vaccine designed to prevent nicotine from entering the brain to help smokers quit. The hosts argue that "vaccine" is the wrong terminology for an addiction treatment and note that the new U.S. healthcare bill mandates no co-payments for vaccines. They characterize this as a guaranteed revenue stream for pharmaceutical companies like Pfizer and AstraZeneca.
